September 03, 2021
Teva Pharmaceuticals has voluntarily dropped its claims against Amicus Therapeutics Inc., which it had accused of hoarding supplies of a costly brand-name medication in violation of a new federal law aimed at providing generic drug manufacturers with predictable supplies of new medicines to aid in bringing unbranded alternatives to market.
July 13, 2021
A Teva Pharmaceuticals subsidiary on Tuesday accused Amicus Therapeutics Inc. of hoarding supplies of a costly brand-name medication, in violation of a new federal law aimed at providing generic-drug makers with predictable supplies of new medicines to aid in bringing unbranded alternatives to market.